A B S T R A C T The role of the human testis in the production of 17fi-estradiol (E2) was investigated by determining the concentration of E2 and testosterone in peripheral and spermatic vein plasma samples. Specimens were obtained from eight normal men, three men with hypogonadism, and two patients with the incomplete form of the feminizing testes syndrome. For comparison, similar studies were performed in four monkeys, 10 mongrel dogs, and 4 additional dogs who were given 1000 IU of human chorionic gonadotropin/day for 5 days. Plasma E2 was measured by radioimmunoassay utilizing sheep anti-E2 serum preceded by ether extraction and thin layer chromatographic separation of plasma steroids. Procedural blanks, which were subtracted from all reported values were 14.1 +0.74 (SEM) pg for deionized water and 13.1 ±0.66 pg for charcoaladsorbed pooled male plasma. Pooled male and pooled female control plasmas averaged 17 ±0.71 pg/ml and 95 +6.9 pg/ml, respectively; individual adult male specimens ranged between 8 and 28 with a mean of 18 ±1.4 pg/ml. In the eight normal men, the mean peripheral vein E2 concentration
INTRODUCTION
The role of the human testis in estrogen production has been a controversial subject for many years. As early as the late 1920's, estrogen was found in normal male urine by bioassay (1) (2) (3) (4) . Steinach and Kun in 1937 (5) and later West, Damast, Sarro, and Pearson (6) , demonstrated that parenteral testosterone could be converted to estrogens. Leach, Maddock, Tokuyama, Paulsen, and Nelson (7) and others (8) (9) (10) (11) showed that HCG increased urinary estrogen excretion while 824 The Journal of Clinical Investigation Volume 51 1972 castration produced a fall. With advances in chemical and tracer methodology, E2 was isolated from human testes (12) , E2 synthesis from acetate weas demonstrated in testicular homogenates (13) , and radiolabeled androgens were shown to be estrogen precursors in blood (14, 15) and urine (16) (17) (18) .
Quantitative studies of the source of estrogens in men indicated that peripheral conversion could not account for all of estrone (Ei) production. However, Brenner, Hutchinson, Siiteri, and MacDonald (19) concluded that all of E2 production could be accounted for by peripheral conversion while Longcope, Kato, and Horton (15) stated that at least 50% of E2 production was derived from peripheral conversion. Direct proof of the secretion of a hormone requires the demonstration of a greater concentration in the venous effluent of the gland than in the peripheral blood. Testicular-estrogen gradients have been demonstrated in six male pseudohermaphrodites with the syndrome of feminizing testes (20) (21) (22) and in one male with gynecomastia (23) . However, the secretion of estrogens by normal testes had not been established before the simultaneous reports by Leonard, Flocks, and Korenman (24) and from our laboratory (25) at the 53rd meeting of the Endocrine Society.
The purpose of this study was to determine whether the normal human testis secretes E2 by measuring E2 in peripheral and spermatic venous samples in men. For comparison, results of similar studies in monkeys, dogs, and in patients with primary hypogonadism and in male pseudohermaphrodites with the incomplete feminizing testes syndrome are also presented.
METHODS
Subjects. Peripheral and spermatic venous blood samples were drawn from eight normal men (23-61 yr old) during an elective herniorrhaphy (seven subjects) or varicocelectomy (one subject) under spinal anesthesia. The spermatic venous samples were obtained by carefully inserting a 21 gauge scalp vein needle into a large venule of the spermatic plexus, close to the external inguinal ring. Paired specimens were also obtained from two subjects with unilateral testicular atrophy, one subj ect with oligospermia and a varicocele, and two patients with the incomplete form of the feminizing testes syndrome. Both patients with "partial" feminizing testes had an XY karotype, female body habitus including breast development, minimal (L. B.) to modest virilization (C. R.), and inguinal testes and epididymis with Leydig cell hyperplasia and defective spermatogenesis. L. B. (age 13 yr, 5 months) was given daily intramuscular injections of 1000 IU of human chorionic gonadotropin (HCG)1 for the 4 days before her orchiectomy. Informed consent was obtained from all subjects in this study. ' Abbreviations used in this paper: A4A, androstendione; DHEA, dehydroepiandrosterone; FSH, follicle-stimulating hormone; HCG, human chorionic gonadotropin; LH, luteinizing hormone.
Femoral arterial and spermatic venous blood samples were obtained from 10 mongrel dogs while under barbiturate anesthesia. An additional four mongrel dogs were given 1000 IU of HCG (A.P.L., Ayerst) intramuscularly/day for 5 days with peripheral venous specimens drawn before treatment.2 Femoral arterial and spermatic venous samples post-HCG were obtained under control conditions. Paired specimens were also obtained from four adult male monkeys.
The plasma concentrations of LH and FSH were determined by a double-antibody radioimmunoassay, as previously described utilizing the highly purified NIH pituitary standards LER 960 for luteinizing hormone (LH) and LER 869 for follicle-stimulating hormone (FSH) (26, 27) .3 Plasma testosterone concentrations were determined by competitive protein-binding analysis (28) .
17f3-Estradiol radioimmunoassay. 2, 4, 6, 7 8H-l7f-Estradiol (SA 95 Ci/mmole) obtained from New England Nuclear Corporation, Boston, Mass., was used without further purification. Radiochemical homogeneity (> 95%) of the 3H-E2 was frequently verified by thin-layer chromatography (Gelman ITLC-SA: benzene: ethyl acetate, 4.1). Rivanoltreated and bovine serum albumin-absorbed sheep antiserum to 17f-estradiol-17 succinyl-BSA was kindly supplied by Dr. Raymond Vande Wiele of Columbia University. 1-ml portions of a 1:10,000 dilution of this antiserum were stored at -20'C and were diluted with 0.1 M phosphate buffer to a final concentration of 1: 500,000 immediately before each assay. After the addition of 1000 cpm of 3H-E2 to monitor procedural losses, 0.1-2.0 ml plasma samples were treated with 1/10th volume 1 N NaOH and then extracted twice with 5-10 ml of freshly distilled, anesthetic grade anhydrous diethyl ether. The combined ether extracts were evaporated under air at 370 C and then submitted to thin-layer chromatography (Gelman ITLC-SA) in a 4:1, benzene: ethyl acetate system after a preliminary development with benzene alone: estrone (Rf = 0.77) ; 17,8-estradiol (Rf = 0.61); testosterone (Rf = 0.45). The 2 X 2 cm EB areas were localized by comparison with a "cold" E2 marker and placed in 2.0 ml deionized water before reextraction twice with 5 ml diethyl ether. The combined ether extracts were evaporated to dryness in 12 X 75 mm disposable, methanol-washed assay tubes. The residues were dissolved in 1.0 ml spectrograde MeOH, and 0.2 ml was removed for monitoring recovery (average recovery= 61 ± 1% SEM) and the remaining 0.8 ml was evaporated to dryness and submitted to radioimmunoassay. All of the spermatic vein samples were processed utilizing two or more different plasma portions.
A 10 point standard curve was prepared in triplicate using 5-300 pg of authentic estradiol (Cal-Biochem). Unknowns and standards were dissolved in 0.6 ml of 0.1 M phosphate buffer followed by the sequential addition of 0.1 ml portions of 0.1% Knox gelatin,' 1/500,000 antibody solution and 8H-Bs (12,000 cPM/0.1 ml phosphate buffer).
Control tubes without antibody were run in all assays. After the addition of 8H-E2, the tubes were swirled for 5 sec 2This study was performed with the assistance of Dr. F. Ganong and Mr. Roy Shackelford of the Department of Physiology, University of California San Francisco under U. S. Public Health Service Grant No. AM-06074. 3Conversion factors to LER 907 in this assay system are:
and incubated for 2 hr at room temperature. Bound and free E2 were separated by the addition of 0.1 ml of dextrancoated charcoal (0.5% Norit A, 0.05% dextran-80 in phosphate buffer). After the addition of charcoal, the contents were vigorously mixed, the tubes placed in an ice bath for 1 hr, and then centrifuged for 10 min at 3000 RPM and 4'C.
The supernatants, containing the bound fraction, were decanted into glass scintillation vials and counted for 20 min in a liquid scintillation counter (Packard TriCarb model 3375) using 10 ml of a modified Bray's solution. Counting efficiency was 30%. Absolute binding varied between 40 and 50%; in the control tubes, 2.7 ±0.2% SEM of the total 'H-E2 remained in the supernatant.
The reproducibility of the standard curve, plotted as B/Bo versus picograms of estradiol, is illustrated in Fig.  1 . When plotted semilogarithmically, a linear relationship was obtained between 15 and 200 pg (Fig. 2 ). Cross-reactivity of E1 was 30-60% while the cross-reactivity of testosterone was insignificant (<0.001%o).
Blank and control values. 2 ml deionized water and charcoal-adsorbed plasma specimens were processed completely for each assay and averaged 14.1 +0.74 and 13.1 +0.66 pg, respectively. In an attempt to determine the source of the methodologic blank, a reagent blank (water/ ether and methanol) was incorporated into each assay tube in eight assays. This yielded a residual plasma blank of 8.3 +1.1 pg, presumably secondary to the chromatographic step. Procedural blanks were always subtracted before the calculation of the reported values. Pooled male and pooled female plasma samples averaged 17 +0.71 pg/ml and 95 +6.9 pg/ml, respectively, while individual adult male specimens ranged between 8 and 28 with a mean of 18 +1.4 pg/ml. Interassay coefficient of variation was 24% for the pooled male plasma and 17.7%o for the pooled female plasma.
The results of the addition of 25-200 pg of "cold" Es to 2.0 ml charcoal-adsorbed plasma aliquots are graphically illustrated in Fig. 3 .
RESULTS
Normal and hypogonadal men. Table I lists The mean peripheral plasma E. concentration in this group of normal male subjects was 20 ±1.6 pg/ml, while the mean concentration in spermatic vein plasma was 50 times as great, 1049 ±57 pg/ml. The mean peripheral testosterone concentration, 5.97 ±0.52 ng/ml, agreed well with our previously reported normal male values, 6.25 +0.27 ng/ml (28) . The mean spermatic vein testosterone concentration was 712 ±79 ng/ml, a 110-fold testicular gradient for testosterone. The three patients with testicular abnormalities (patients I, J, and K), two with unilateral atrophy, and one with oligospermia, all had normal peripheral E2 values, but low concentrations of spermatic vein E2. Two of the three (I and K) had low spermatic vein testosterone concentrations, although their peripheral testosterone values were in the normal male range. Feminizing testes syndrome. The results of our studies in two patients with the incomplete form of the feminizing testes syndrome are illustrated in Fig. 4 . Testicular gradients of dehydroepiandrosterone (DHEA) and androstendione (AA) were also determined in patient C.R. and three control subjects. C.R., age 16 terone concentration (3.37 ng/ml) found in advanced puberty in boys. Spermatic vein concentrations of DHEA, 120 ng/ml, and A4A, 53.2 ng/ml, were twice normal (three normals: mean DHEA 64.3 ±7.1 ng/ ml SD; mean A'A 22.3 ±+13.6 ng/ml SD). Spermatic vein testosterone was high normal; however, the spermatic vein E2 was greater than 4600 pg/ml, at least four times normal. Preoperatively, LH was elevated at 8.5 ng/ml and rose to 14.4 ng/ml postoperatively. In contrast, the concentration of plasma FSH was normal (2.2 ng/ml) preoperatively, but rose strikingly to 54 ng/ml 8 days after a bilateral orchiectomy. L.B. had similar control values for testosterone and E2. After 4 days of HCG treatment, a significant rise in testosterone and a probable rise in E2 were noted in peripheral blood. After treatment with HCG, spermatic vein testosterone concentration was in the high normal range, whereas spermatic vein E2 was 2200 pg/ml, approximately twice the normal value for adult males. After orchiectomy, peripheral DHEA and A'A in C.R. dropped from 6.9 to 2.3 ng/ml and 1.3 to 0.5 ng/ml, respectively, while testosterone and E2 were virtually undetectable in both patients.
Monkeys. Four monkeys (Table II) had peripheral E2 concentrations similar to those in normal men ( < 7-33 pg/ml), but their spermatic vein E2 concentrations averaged only 50 pg/ml. Monkey 4 had a remarkably high spermatic vein testosterone value (81.4 ng/ml), while his peripheral testosterone concentration was similar to the other animals. With the inclusion of monkey 4, the mean simian testicular gradients for E2 and testosterone were only 3and 10-fold, respectively. (24) . The testicular testosterone gradient of 706 ng/ml in normal men agrees well with the recent report by Laatikainen, Laitinen, and Vihko (29) and falls within the wide range of values previously reported (30) (31) (32) . Comparison of the results in man with two other mammalian species reveals that the simian and canine testes also secrete E2, but in smaller amounts. In all three species, testicular testosterone gradients were greater than the E2 gradients.
The peripheral E2 and testicular E2 gradients in this group of mongrel dogs must be regarded as approximate values only since most dogs had undetectable (< 7 pg/ml) peripheral E2 levels. This finding agrees well with previous reports indicating either low or absent estrogen excretion in dogs (33) . Siegel, Forchielli, Dorfman, Brodey, and Prier, using a fluorometric technique, found a small testicular E2 gradient in three out of four normal dogs, but the reported spermatic vein concentrations were much higher (average of five dogs: 470 pg/ml), attributable to the apparent relative insensitivity of their technique (34) . The lack of a significant rise in peripheral or spermatic vein E2 concentrations in the HCG-treated dog may merely reflect our current inability to precisely define low basal values or the marked heterogeneity of values found in this small group of mongrel dogs. Since HCG-treated normal men exhibit an increase in peripheral E2 concentrations,' there may be a species difference either in peripheral aromatization of androgens or testicular responsiveness to HCG.
Feminizing testes syndrome. The concentration of plasma E2 in testicular venous plasma has been reported in five patients with the complete form (20, 21) and one patient with the incomplete form of the feminizing testes syndrome (22) . (The reported values range from 3,100 to 20,000 pg/ml). The results in our two patients, obtained by the more sensitive and specific radioimmuno-assay technique, confirm that the testes in this syndrome secrete significant amounts of E2. The (22) or to an increased metabolic clearance rate. The discordance between the plasma FSH and LH values, as reflected by the elevated LH and normal FSH concentrations preoperatively in C.R., is similar to data presented by Faiman and Winter (35) . These findings, in light of the known end-organ androgen unresponsiveness which seems to include impaired testosterone suppression of LH secretion, suggest that E2 is the principal sex steroid controlling gonadotropin secretion in these patients and are further evidence for separate feedback mechanisms for LH and FSH.
Estimation of testicular Es secretion. The determination of the testicular E2 gradient alone does not permit a direct calculation of testicular E2 secretion. However, based upon the mean testosterone blood production rate of 7 mg/day for normal adult males (36) and upon the experimentally determined testosterone and estradiol gradients, the testicular E2 secretion is estimated at 10 ttg/day. A comparison of the reported production rates of E2 (approximately 40 Iug/day) (15, 19) with our estimate of testicular E2 secretion indicates that testicular secretion may account for approximately one-fourth of E2 production in normal men.
No attempt was made in this study to determine the testicular site of aromatization of C19 precursors to estradiol, whether this occurs primarily in the Leydig cells, the seminiferous tubules, or in both compartments. Such studies would enhance our understanding of the origin and physiologic significance of Et in men. The observations reported herein direct attention to the possible role of E2 arising from the testis as well as from conversion from precursor steroids in peripheral tissues, in the regulation of FSH secretion in the male.
